医学综述
醫學綜述
의학종술
Medical Recapitulate
2015年
17期
3232-3234
,共3页
非瓣膜性心房颤动%老年%华法林%血栓栓塞
非瓣膜性心房顫動%老年%華法林%血栓栓塞
비판막성심방전동%노년%화법림%혈전전새
Nonvalvular atrial fibrillation%Elderly%Warfarin%Thromboembolism
目的:探讨华法林预防老年非瓣膜性心房颤动患者血栓栓塞的治疗效果及应用价值。方法选择2010年3月至2013年3月泸州市第四人民医院心内科治疗的老年非瓣膜性心房颤动患者88例,按照随机数字表法分为两组。对照组(44例)给予阿司匹林(每日1次,每次0.1 g,睡前口服)治疗,观察组(44例)给予华法林(初始剂量2.5 mg/d,之后根据凝血功能调整,每次增减0.625 mg,口服给药)联合胺碘酮(初始剂量每次0.2 g,每日3次,治疗2周后每次0.2 g,每日1次,口服给药)治疗。观察两组患者的临床治疗情况。结果观察组患者左心室射血分数和左心房内径改善情况优于对照组,差异有统计学意义(P<0.01)。观察组患者栓塞事件发生率和出血并发症发生率均低于对照组,差异有统计学意义( P<0.05或P<0.01)。结论采用华法林联合胺碘酮预防老年非瓣膜性心房颤动患者血栓栓塞效果可靠,可减少出血并发症发生,同时可以改善患者左心室射血分数和左心房内径。
目的:探討華法林預防老年非瓣膜性心房顫動患者血栓栓塞的治療效果及應用價值。方法選擇2010年3月至2013年3月瀘州市第四人民醫院心內科治療的老年非瓣膜性心房顫動患者88例,按照隨機數字錶法分為兩組。對照組(44例)給予阿司匹林(每日1次,每次0.1 g,睡前口服)治療,觀察組(44例)給予華法林(初始劑量2.5 mg/d,之後根據凝血功能調整,每次增減0.625 mg,口服給藥)聯閤胺碘酮(初始劑量每次0.2 g,每日3次,治療2週後每次0.2 g,每日1次,口服給藥)治療。觀察兩組患者的臨床治療情況。結果觀察組患者左心室射血分數和左心房內徑改善情況優于對照組,差異有統計學意義(P<0.01)。觀察組患者栓塞事件髮生率和齣血併髮癥髮生率均低于對照組,差異有統計學意義( P<0.05或P<0.01)。結論採用華法林聯閤胺碘酮預防老年非瓣膜性心房顫動患者血栓栓塞效果可靠,可減少齣血併髮癥髮生,同時可以改善患者左心室射血分數和左心房內徑。
목적:탐토화법림예방노년비판막성심방전동환자혈전전새적치료효과급응용개치。방법선택2010년3월지2013년3월로주시제사인민의원심내과치료적노년비판막성심방전동환자88례,안조수궤수자표법분위량조。대조조(44례)급여아사필림(매일1차,매차0.1 g,수전구복)치료,관찰조(44례)급여화법림(초시제량2.5 mg/d,지후근거응혈공능조정,매차증감0.625 mg,구복급약)연합알전동(초시제량매차0.2 g,매일3차,치료2주후매차0.2 g,매일1차,구복급약)치료。관찰량조환자적림상치료정황。결과관찰조환자좌심실사혈분수화좌심방내경개선정황우우대조조,차이유통계학의의(P<0.01)。관찰조환자전새사건발생솔화출혈병발증발생솔균저우대조조,차이유통계학의의( P<0.05혹P<0.01)。결론채용화법림연합알전동예방노년비판막성심방전동환자혈전전새효과가고,가감소출혈병발증발생,동시가이개선환자좌심실사혈분수화좌심방내경。
Objective To explore the therapeutic effect and application value of warfarin in prevention of thromboembolism in elderly patients with nonvalvular atrial fibrillation. Methods A total of 88 elderly patients with nonvalvular atrial fibrillation were chosen in Luzhou City Fourth People′s Hospital from Mar. 2010 to Mar. 2010. According to random number table method the patients were divided into two groups:control group ( 44 cases ) and observation group ( 44 cases ) . The control group was treated with aspirin (0. 1 g/time,1 time/d,orally at bedtime) treatment,while the observation group was treated with warfarin ( after the initial dose of 2. 5 mg/d,according to blood coagulation function adjustment,increase or decrease by 0.625 mg each time,orally) joint amiodarone (initial dose of 0. 2 g/time,3 times/d,after treatment for 2 weeks,0. 2 g/time,1 time/d,orally) treatment. The clinical treatment effect of the two groups were observed. Results Improvement of left ventricular ejection fraction and left atrial diameter of the observation group was better than that of the control group,the difference was statistically significant(P<0. 01). Incidences of embol-ism and bleeding complications of the observation group were lower than the control group,the difference was statistically significant(P<0. 05 or P<0. 01). Conclusion Amiodarone combined with warfarin joint pre-vention of thromboembolism in elderly patients with nonvalvular atrial fibrillation has reliable effect, which can reduce bleeding complications,and improve left ventricular ejection fraction and left atrial diameter.